ERA-923
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ERA-923, covering 2013-11-06 to 2013-11-06. Get the full timeline:
Most recent: Clinical Trial Update: ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer [Phase 2]